NCT06888583 is a clinical trial of Transpedicular fixation in Fixation, sponsored by Tanta University.

Who is sponsoring NCT06888583?

NCT06888583 is sponsored by Tanta University.

What drugs are being tested in NCT06888583?

Interventions in NCT06888583: Transpedicular fixation.

What condition does NCT06888583 study?

NCT06888583 studies Fixation, Unstable Sacral Fractures, Transpedicular Sacral Fixation.

Is NCT06888583 still recruiting?

NCT06888583 is currently completed. Last updated 21 March 2025.

Last reviewed 2025-03-21 · How we verify

NCT06888583

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fixation of Unstable Sacral Fractures by Transpedicular System

Completed Last updated 21 March 2025

What this trial tests

trial testing Transpedicular fixation in Fixation in 21 participants. Completed in 1 August 2024.

Timeline

1 May 2022

Primary endpoint
1 August 2024

1 August 2024

Quick facts

Lead sponsor	Tanta University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	21
Start date	1 May 2022
Primary completion	1 August 2024
Estimated completion	1 August 2024
Sites	1 location across Egypt

Drugs / interventions tested

Transpedicular fixation

Conditions studied

Fixation — all drugs for Fixation →
Unstable Sacral Fractures — all drugs for Unstable Sacral Fractures →
Transpedicular Sacral Fixation — all drugs for Transpedicular Sacral Fixation →

Sponsor

Tanta University

Who can join

18 and older, any sex, with Fixation or Unstable Sacral Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aimed to assess the role of the transpedicular Fixation system in the management of unstable sacral fractures in adults.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fixation of unstable sacral fractures by transpedicular system: a prospective study.
Elmoghany ME, Gharbo NO, Ayoub MA, Farouk OA, et al · · 2026 · PMID 41233652 · DOI 10.1007/s00264-025-06673-3

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06888583 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 21 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06888583.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing